The Wilberforce Society | Public Health Regarding Medical Treatments
112
post-template-default,single,single-post,postid-112,single-format-standard,ajax_fade,page_not_loaded,,vertical_menu_enabled,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

Public Health Regarding Medical Treatments

A proposal to improve efficacy, safety and cost-effectiveness of medical treatment in five ways: firstly, to publicly run all Phase III clinical trials, secondly to only approve drugs for treating a particular condition rather than for general sale, thirdly that NICE must consider a treatment cost-effective for each condition for it to be approved to treat that condition, fourthly to cap NHS drug prices at £20k/patient/QUALY, and finally to allow the NHS to produce combined medications. Updated in August 2011 in response to the impending move to value based pricing.

Download (PDF, 131KB)

No Comments

Sorry, the comment form is closed at this time.